rs1626923

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001355436.2(SPTB):​c.4293A>G​(p.Arg1431Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.337 in 1,613,268 control chromosomes in the GnomAD database, including 96,736 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 13942 hom., cov: 31)
Exomes 𝑓: 0.33 ( 82794 hom. )

Consequence

SPTB
NM_001355436.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.31

Publications

19 publications found
Variant links:
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • elliptocytosis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 14-64779905-T-C is Benign according to our data. Variant chr14-64779905-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 257117.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.31 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.623 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTBNM_001355436.2 linkc.4293A>G p.Arg1431Arg synonymous_variant Exon 21 of 36 ENST00000644917.1 NP_001342365.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTBENST00000644917.1 linkc.4293A>G p.Arg1431Arg synonymous_variant Exon 21 of 36 NM_001355436.2 ENSP00000495909.1 P11277-2
SPTBENST00000553938.5 linkc.288A>G p.Arg96Arg synonymous_variant Exon 2 of 18 1 ENSP00000451324.1 H0YJE6
SPTBENST00000389722.7 linkc.4293A>G p.Arg1431Arg synonymous_variant Exon 20 of 35 2 ENSP00000374372.3 P11277-2
SPTBENST00000389720.4 linkc.4293A>G p.Arg1431Arg synonymous_variant Exon 21 of 32 5 ENSP00000374370.4 P11277-1

Frequencies

GnomAD3 genomes
AF:
0.402
AC:
61031
AN:
151840
Hom.:
13911
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.629
Gnomad AMI
AF:
0.297
Gnomad AMR
AF:
0.267
Gnomad ASJ
AF:
0.330
Gnomad EAS
AF:
0.364
Gnomad SAS
AF:
0.412
Gnomad FIN
AF:
0.302
Gnomad MID
AF:
0.358
Gnomad NFE
AF:
0.318
Gnomad OTH
AF:
0.373
GnomAD2 exomes
AF:
0.336
AC:
84212
AN:
250516
AF XY:
0.339
show subpopulations
Gnomad AFR exome
AF:
0.638
Gnomad AMR exome
AF:
0.190
Gnomad ASJ exome
AF:
0.327
Gnomad EAS exome
AF:
0.364
Gnomad FIN exome
AF:
0.299
Gnomad NFE exome
AF:
0.322
Gnomad OTH exome
AF:
0.328
GnomAD4 exome
AF:
0.330
AC:
482373
AN:
1461310
Hom.:
82794
Cov.:
45
AF XY:
0.332
AC XY:
241371
AN XY:
726948
show subpopulations
African (AFR)
AF:
0.645
AC:
21586
AN:
33474
American (AMR)
AF:
0.200
AC:
8958
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.332
AC:
8686
AN:
26136
East Asian (EAS)
AF:
0.353
AC:
14011
AN:
39698
South Asian (SAS)
AF:
0.399
AC:
34455
AN:
86254
European-Finnish (FIN)
AF:
0.296
AC:
15792
AN:
53320
Middle Eastern (MID)
AF:
0.342
AC:
1970
AN:
5768
European-Non Finnish (NFE)
AF:
0.320
AC:
355570
AN:
1111572
Other (OTH)
AF:
0.354
AC:
21345
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
18615
37230
55846
74461
93076
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11706
23412
35118
46824
58530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.402
AC:
61106
AN:
151958
Hom.:
13942
Cov.:
31
AF XY:
0.400
AC XY:
29677
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.630
AC:
26082
AN:
41428
American (AMR)
AF:
0.267
AC:
4078
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.330
AC:
1143
AN:
3468
East Asian (EAS)
AF:
0.363
AC:
1871
AN:
5160
South Asian (SAS)
AF:
0.412
AC:
1981
AN:
4814
European-Finnish (FIN)
AF:
0.302
AC:
3183
AN:
10552
Middle Eastern (MID)
AF:
0.371
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
0.318
AC:
21599
AN:
67952
Other (OTH)
AF:
0.374
AC:
790
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1732
3464
5197
6929
8661
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
566
1132
1698
2264
2830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.344
Hom.:
21408
Bravo
AF:
0.406
Asia WGS
AF:
0.418
AC:
1456
AN:
3478
EpiCase
AF:
0.323
EpiControl
AF:
0.326

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spherocytosis type 2 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
8.4
DANN
Benign
0.71
PhyloP100
-1.3
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1626923; hg19: chr14-65246623; COSMIC: COSV67633848; API